NSN 6505-01-656-4228, (6505016564228) - Fentanyl Transdermal System Parts List
Fentanyl Transdermal System parts under NSN 6505-01-656-4228 manufactured by Janssen Pharmaceuticals Inc, Mallinc Krodt Inc, Mylan Pharmaceuticals Inc, Sandoz Inc. All NSN items provided by NSN Parts Hub are compliant with fit, form, and functionality according to parameters set by the DLA. With over 3 billion new and obsolete parts in our searchable database, you can find your required part number of NSN 6505-01-656-4228 with ease when you use NSN Parts Hub as your purchasing partner. We maintain an unmatched supply-chain network with trusted MFRs and verified PMAs and are the only distributor with a No China Sourcing pledge. Do you require part numbers other than NDC50458-0090-05, NDC00406-9012-76, NDC00378-9119-98, NDC00781-7240-55? Related NSN parts are listed below for your convenience.
Would you like a quote for NSN 6505-01-656-4228 Parts?
Simply submit an Instant RFQ for needed parts.
Alternative NSN: 6505016564228 |
Item Name: Fentanyl Transdermal System |
NIIN: 016564228 |
NCB Code: USA (01) |
Manufacturers: Janssen Pharmaceuticals Inc , Mallinc Krodt Inc , Mylan Pharmaceuticals Inc , Sandoz Inc |
Part No | Manufacturer | Item Name | QTY | RFQ |
---|---|---|---|---|
NDC50458-0090-05 | janssen pharmaceuticals inc | fentanyl transdermal system | Avl | RFQ |
NDC00406-9012-76 | mallinc krodt inc | fentanyl transdermal system | Avl | RFQ |
NDC00378-9119-98 | mylan pharmaceuticals inc | fentanyl transdermal system | Avl | RFQ |
NDC00781-7240-55 | sandoz inc | fentanyl transdermal system | Avl | RFQ |
Characteristics Data of NSN 6505016564228
MRC | Criteria | Characteristic |
---|---|---|
FEAT | Special Features | ROUTE: TRANSDERMAL; DOSE FORM: PATCH, TRANSDERMAL 72 HOURS; STRENGTH: 12 MCG/HOUR; DEA CONTROLLED II SUBSTANCE; INDIVIDUALLY SEALED; CONTAINS FIVE (12 MCG/HR) TRANSDERMAL SYSTEMS; STORE IN ORIGINAL UNOPENED POUCH; STORE UP TO 20 C TO 25 C (68 F TO 77 F); STRICT ADHERENCE TO THE RECOMMENDED HANDLING AND DISPOSAL INSTRUCTIONS ON PRODUCT INSERT IS OF THE UTMOST IMPORTANCE TO PREVENT ACCIDENTAL EXPOSURE; EXPOSURE OF FENTANYL TRANSDERMAL SYSTEM APPLICATION SITE AND SURROUNDING AREA TO DIRECT EXTERNAL HEAT SOURCES, SUCH AS HEATING PADS, SAUNAS, HOT TUBS AND HEATED WATER BEDS MAY INCREASE FENTANYL ABSORPTION AND RESULT IN FATAL OVERDOSE OF FENTANYL AND DEATH; PATIENTS WHO DEVELOP FEVER OR INCREASED CORE BODY TEMPERATURE DUE TO STRENOUS EXERTION ARE ALSO AT RISK FOR INCREASED FENTANYL EXPOSURE AND MAY REQUIRE AN ADJUSTMENT IN THE DOSE OF FENTANYL TRANSDERMAL SYSTEM TO AVOID OVERDOSE |
CSLZ | Usual Dose | 12 MCG/HR |
CBBL | Features Provided | INDIVIDUALLY SEALED |
CRYC | Controlled Substance Classification | SCHEDULE II |
CXCY | Part Name Assigned By Controlling Agency | DURAGESIC-12 (FENTANYL TRANSDERMAL SYSTEM) 12MCG/HR, 5S |
MRC | Decoded Requirement | Clear Text Reply |
6505-01-656-4228, 6505016564228 Search Related NSN Catalog
Top National Stock Numbers
5306013334523 |
7490013953355 |
6140014469498 |
7025015900737 |
3130015369045 |
4730009541281 |
6240001557836 |
5965016488042 |
5330012852788 |
7210000527327 |